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Numerous disease states are associated with hemolysis or hemorrhage. Because red cells in the extravascular space tend to lyse
quickly, hemoglobin (Hb) is released and is prone to autoxidation producingMetHb. Inorganic and organic peroxides may convert
Hb and MetHb to higher oxidation states such as ferrylHb. FerrylHb is not a single chemical entity but is a mixture of globin- and
porphyrin-centered radicals and covalently cross-linked Hbmultimers. Oxidized Hb species are potent prooxidants caused mainly
by heme release from oxidized Hb. Moreover, ferrylHb is a strong proinflammatory agonist that targets vascular endothelial cells.
This proinflammatory effect of ferrylHb requires actin polymerization, is characterized by the upregulation of proinflammatory
adhesion molecules, and is independent of heme release. Deleterious effects of native Hb are controlled by haptoglobin (Hp) that
binds cell-free Hb avidly and facilitates its removal from circulation through the CD163 macrophage scavenger receptor-mediated
endocytosis. Under circumstances of Hb oxidation, Hp can prevent heme release fromMetHb, but unfortunately the Hp-mediated
removal of Hb is severely compromised when Hb is structurally altered such as in ferrylHb allowing deleterious downstream
reactions to occur even in the presence of Hp.
1. Introduction
The red cell is usually a blessing but sometimes a curse. The
normal red cell efficiently binds oxygen from the atmosphere,
delivers it to the tissues, and helps remove the product of
metabolic combustion, carbon dioxide. Nice. But the same
cells can be involved in pathophysiologicmischief upon hem-
orrhage or intravascular hemolysis. Once outside the vascular
system, red cells quickly burst releasing free hemoglobin
(Hb). That Hb is prone to spontaneous oxidation (as the
scientists trying to develop Hb-based blood substitutes have
repeatedly discovered). Even worse, theHbmay be converted
to higher oxidation states such as ferrylHb which have potent
proinflammatory and prooxidant effects, either directly or
via the release of heme which itself is highly prooxidant.
Here, we briefly describe what is known regarding the natural
mechanisms which have evolved to control this cell-free
hemoglobin and what is being learned about the biologic
effects of Hb once it is released from the red cell in pathologic
states.
2. Antioxidant Network of Erythrocytes
Hemoglobin (Hb) autoxidation is the main source of reactive
oxygen species inside erythrocytes. Taking into consideration
the high intraerythrocytic concentration of Hb—around
5mM as tetramer—even a slow rate of autoxidation could
generate substantial amounts of ROS. To cope with this
challenge, erythrocytes are equipped with highly effective
antioxidant defenses [1]. This system includes enzymes such
as Cu/Zn superoxide dismutase (SOD1) that convert superox-
ide anion to hydrogen peroxide (H
2
O
2
), catalase (Cat), glu-
tathione peroxidase (Gpx-1), and peroxiredoxins (Prdx1 and
Prdx2) which decompose H
2
O
2
to H
2
O. Nonenzymatic scav-
engers such as glutathione also contribute to this protection.
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Gene knock-out mouse models have been used to esti-
mate the relative importance of these antioxidant defenses.
Surprisingly, under steady-state conditions, mice deficient in
either Gpx-1 [2] or Cat [3] have a normal phenotype. How-
ever, Cat seems to be essential for protection against elevated
levels of H
2
O
2
since Cat deficient erythrocytes are very sen-
sitive to exogenous H
2
O
2
[4]. It has been suggested that ery-
throcyte Cat might function as a “sink” for extra-erythrocytic
H
2
O
2
and thus protect somatic cells against exogenous
oxidant challenge [5]. In contrast to Gpx1−/− or Cat−/−
mice, Prdx1−/−, Prdx2−/−, and SOD1−/−mice exhibit impaired
erythrocyte antioxidant defense. As a result, concentrations
of ROS are elevated and accompanied by hemolytic anemia
in SOD1−/− [6], Prdx1−/− [7], and Prdx2−/− mice [8].
The idea that Hb itself may have antioxidant properties
and thus contribute to the antioxidant network of erythro-
cytes emerged recently. For example, the Hb 𝛽93 cysteine
(𝛽93Cys)—highly conserved in vertebrates—has been shown
to scavenge superoxide anion produced in the heme pocket
of the 𝛽-chain of Hb [9]. This reaction may be beneficial as
it decreases the rate of Hb autoxidation and reduces heme
degradation attributed to the reaction of superoxide with the
heme [9]. The contribution of this Hb residue to erythrocyte
antioxidant protection might be considerable because of
its high concentration. Knock-in mouse models—in which
erythrocytes contained wild-type human Hb or human Hb
in which the 𝛽93 cysteine residue was replaced with Ala—
were generated to directly explore the role of the conserved
𝛽93Cys [10]. While the authors did not observe hemolysis
or hemolytic disorders in the 𝛽93Ala mice, they found that
𝛽93Ala Hb has higher reactivity toward H
2
O
2
than 𝛽93Cys
Hb [11]. When 𝛽93Ala Hb was reacted with H
2
O
2
, elevated
formation of highmolecular weight, presumably cross-linked
Hb species were observed, suggesting that the 𝛽93Cys residue
plays a protective role in the metabolism of reactive species
produced by erythrocytes under stress conditions [11]. This
notion was further supported by experiments in which
oxidative stresswas engendered in vivo inmice by challenging
them with lipopolysaccharide (LPS). The authors found that
LPS provoked more pronounced lung injury and a greater
degree of hypotension in 𝛽93Ala versus 𝛽93Cys mice. These
effects were accompanied by elevated level of erythrocyte
reactive oxygen species [11].
Finally, the erythrocyte enzyme, NADH methemoglobin
(MetHb) reductase (Aka diaphorase I) also contributes to the
antioxidant network of the erythrocyte. Continuous exposure
of erythrocyte Hb to oxygen leads to the oxidation of ferrous
(Fe2+) heme to ferric (Fe3+) heme. The resulting MetHb is
unable to carry oxygen. The function of MetHb reductase is
to restore oxygen-binding ability of Hb by reducing ferric ion
into ferrous ion (reviewed in [12]).
3. Oxidation of Hb
Under normal conditions, a very small amount of the oxygen
attached to the Hb heme iron dissociates as superoxide anion
leaving ferric heme. This explains why, in normal people, 1-
2% of Hb is present as MetHb (1). Dismutation of superoxide
anion by SODs generates H
2
O
2
. Numerous in vitro studies
have been performed to describe the peroxide-mediated
oxidation of Hb using purified human Hb.
Peroxides like H
2
O
2
may trigger a two-electron oxida-
tion of Hb producing ferryl (Fe4+=O2−) Hb (2), whereas
the reaction of MetHb with H
2
O
2
yields ferrylHb radical
(Hb∙+(Fe4+=O2−)) in which the unpaired electron is associ-
ated with the globin or the porphyrin ring (3) [13–16]
Hb (Fe2+)O
2
󳨀→ Hb (Fe3+) +O
2
∙− (1)
Hb (Fe2+)O
2
+H
2
O
2
󳨀→ Hb (Fe4+=O2−) +H
2
O +O
2
(2)
Hb (Fe3+) +H
2
O
2
󳨀→ Hb∙+ (Fe4+=O2−) +H
2
O (3)
The high-valence iron compounds are reactive intermediates
and decay by several routes [17]. FerrylHb can initiate further
production of globin radicals via an intramolecular electron
transfer between the ferryl iron and specific amino acid
residues of the globin chains resulting in the formation
of MetHb globin radical (3). Radical/radical termination
of globin- and porphyrin-centered radicals leads to the
production of globin-globin (4) or porphyrin-globin cross-
links
Hb (Fe4+=O2−) + 2H+ 󳨀→ Hb∙+ (Fe3+) +H
2
O (4)
Hb∙+ (Fe3+) +Hb∙+ (Fe3+) 󳨀→ (Fe3+) +Hb–Hb+ (Fe3+)
(5)
Considerable effort has beenmade to explore the mechanism
via which the globin radicals are formed and where they
are located within the protein. Several amino acids on both
𝛼- and 𝛽-globin chains were identified as targets of H
2
O
2
-
triggered oxidation. When Hb was reacted with H
2
O
2
in
the presence of the spin trap 5,5-dimethyl-1-pyrroline N-
oxide (DMPO), several DMPO adducts were formed [18, 19].
Identification of the precise amino acid residues trapped
by the DMPO by mass spectrometry revealed that radical
formation occurs on 𝛽Cys93, 𝛼Tyr24, 𝛼Tyr42, and 𝛼His-20
residues of the globin chains [18]. As part of this latter work,
the authors showed that in the absence of a spin trap, the
globin-centered radicals can decay by formation of cross-
links between the globin chains [18]. Later investigations
identified key amino acids that appear to be highly susceptible
to H
2
O
2
-mediated oxidation [15]. During H
2
O
2
-triggered
Hb oxidation, 𝛽Cys93 and 𝛽Cys112 residues are irreversibly
oxidized to cysteic acids, while oxidative modification of
𝛽Trp-15 and 𝛽Met-55 also occurs [15].These processes might
contribute to the loss of 𝛼-helical structure of the 𝛽 chain
surrounding the heme pocket and eventually lead to the
deformation and collapse of the 𝛽 chains [15].
A number of studies have examined whether H
2
O
2
-
mediated Hb oxidation occurs in intact erythrocytes despite
the above-mentioned highly active antioxidant defense sys-
tems. Giulivi and Davies provided the first evidence for
the formation of ferrylHb in intact red blood cells [20].
Later, the same group detected dityrosine in intact red blood
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cells exposed to H
2
O
2
and provided a mechanism for its
formation. They concluded that dityrosine is a hallmark of
globin-centered tyrosyl radical formation and subsequent
intermolecular cross-linking [21, 22].
Besides H
2
O
2
, oxidized lipids are very important trig-
gers of Hb oxidation. For example, we showed that lipid
hydroperoxides of atheroma lipids convertHb toMetHb [23].
Furthermore, interactions between lipid hydroperoxides of
oxLDL or atheroma lipids result in the formation of ferrylHb
and covalently cross-linked Hb species [23].
3.1.Hb Oxidation In Vivo. Whether oxidation of Hb leading
to the formation of high-valence heme/iron compounds and
globin radicals occurs in vivo was a subject of debate until
recently. These products are transiently formed and can
initiate a range of oxidative reactions with similar reactivity
to the hydroxyl radical. The first piece of evidence that
the above-mentioned reactions occur in vivo came from
the study of Svistunenko et al., in which the authors could
detect ferrylHb globin-centered radicals in normal human
blood by electron paramagnetic resonance spectroscopy [24].
Furthermore, covalently modified heme in Hb was detected
by HPLC in normal human blood [25]. In the latter study, the
authors showed that the concentration of covalentlymodified
heme in Hb is increased by exercise, a surrogate model of
acute oxidative stress [25].
Oxidation of Hb has been shown in certain pathological
conditions. For example, heme-protein cross-linked Hb was
detected in cerebrospinal fluid following subarachnoid hem-
orrhage by reverse phase HPLC [26]. Moreover, recently we
found that the content of dityrosine is elevated and globin-
globin cross-linked Hbmultimers are present in complicated
atherosclerotic lesions in humans [23].
4. Control of Free Hb and Hb-Derived Heme
Several pathological conditions are associated with hemolysis
when Hb is released from erythrocytes into the extracel-
lular milieu [27]. Extracellular Hb exerts vasoactive effects
via scavenging nitric oxide, an important vasodilator and
signaling molecule (reviewed in [27]). Moreover, oxidation
of extracellular Hb triggers prooxidant (reviewed in [28])
and proinflammatory effects on vascular endothelium [29].
Efficient mechanisms have evolved for the removal of Hb
from the circulation to control the deleterious effects of
extracellular Hb. Haptoglobin (Hp), an acute-phase protein,
is present in plasma in high amounts (0.41–1.65mg/mL)
with the exclusive recognized function of capturing cell-free
Hb and chaperoning Hb to macrophages for degradation
(reviewed in [30]). Hp binding facilitates the removal of Hb
from circulation through the CD163 macrophage scavenger
receptor-mediated endocytosis [31] (Figure 1).
The formation of the Hp:Hb complex is virtually irre-
versible, and Hp binding besides facilitating the removal
of intravascular cell-free Hb has many additional beneficial
effects. Several studies showed that Hb bound to Hp is less
prone to H
2
O
2
-mediated oxidation than free Hb [32–34]. In
fact, the Hb:Hp complex acts as a fairly efficient peroxidase
[35]. Further studies proved that Hp prevents H
2
O
2
-induced
oxidation of amino acids in critical regions of Hb chains—
that is, 𝛼Tyr42, 𝛽Tyr145, and 𝛽Cys93—and polymerization
of Hb [36]. The recent determination of the crystal structure
of the porcine Hp:Hb complex revealed that Hb residues
known to be prone to oxidative modifications are buried in
the Hp:Hb interface, thereby explaining this direct protective
role of Hp against H
2
O
2
-induced oxidation [37].
Following internalization by the macrophage, heme is
cleaved by heme oxygenase-1 (HO-1) into biliverdin, carbon
monoxide, and iron. This mechanism not only provides
effective elimination of Hb, but it also assures iron recycling
for de novo erythropoiesis under normal circumstances.
However, in cases of massive intravascular hemolysis, Hp can
be depleted from the circulation in which the case of free
Hb is cleared (rather inefficiently) via a low-affinity pathway
through CD163 [38] and/or by renal excretion [39, 40]. This
latter is accompanied by generation of free iron and organ
damage.
The prooxidant effects of Hb are mainly attributed to
heme release from oxidized Hb. For example, MetHb but
not Hb readily releases its heme prosthetic group which can
be taken up by endothelial cells [41]. As a consequence of
endothelial heme uptake, cells become extremely sensitive
to oxidants like H
2
O
2
or activated inflammatory cells [41].
Endothelial cells exposed to MetHb upregulate HO-1 and
ferritin, key molecules responsible for heme degradation
and safe storage of iron [41]. Heme release and subsequent
endothelial reactions are efficiently blocked byHp [41]. Heme
transfer from oxidized Hb toward low-density lipoprotein
(LDL) and consequent lipid peroxidation is also prevented by
Hp [42] (Figure 1).
However, the protective effects of Hp are not entirely
straightforward. In humans, the Hp gene is polymorphic
resulting in the two functional alleles, that is, 1 and 2, which
can form three different genotypes: Hp1-1, Hp2-1, and Hp2-
2. Because Hp1 is monovalent and Hp2 is bivalent, the
structures of protein products in the three genotypes show
molecular heterogeneity. Hp1-1 is a small dimeric molecule
(86 kDa) whereas Hp2-1 is characterized by linear polymers
(86–300 kDa) and Hp2-2 forms large cyclic polymers (170–
900 kDa) (reviewed in [43]).
The Hp polymorphism was investigated as a possible
genetic determinant in cardiovascular disease. These epi-
demiologic studies revealed that the Hp2-2 genotype is a
risk factor for cardiovascular complications in both type I
and type II diabetic patients (reviewed in [44]). Recently,
it has been shown that Hp2-2 genotype is associated with
elevated amounts of iron in atherosclerotic carotid plaques
in diabetic patients [45] which may imply poor stabilization
of free Hb. The Hp2-2 genotype was found to be accom-
panied by increased macrophage infiltration and decreased
smooth muscle cell content of the atherosclerotic plaque,
two common indicators of plaque instability, in patients with
diabetes [46]. In healthy men, Hp2-2 genotype is found to
be associated with increased circulating oxLDL levels when
compared to Hp1-1 or Hp2-1 genotypes [47]. Recently, the
Hp2-2 genotype has been linked to greater risk of vasospasm
and of clinical deterioration by delayed cerebral ischemia
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Figure 1: Schematic representation of hemoglobin oxidation and the different biological effects of oxidized Hb species. Hb is released from
red blood cells following intra- or extravascular hemolysis. Hb can undergo spontaneous oxidation, or, alternatively, nitric oxide (NO) can
trigger Hb oxidation toMetHb. Peroxidation of Hb andMetHb by H
2
O
2
or lipid hydroperoxides (LOOH) leads to the formation of ferrylHb,
that is, a mixture of globin radicals, porphyrin radicals, and covalently cross-linked Hb multimers. Haptoglobin (Hp) binds extracellular Hb
and facilitates its internalization by macrophages. MetHb and ferrylHb can release heme and induce oxidative modification of lipids such as
low-density lipoprotein (LDL), sensitizing cells to oxidant-mediated killing. FerrylHb is a proinflammatory agonist that targets endothelial
cells. Heme release from oxidized Hb species and peroxidation of Hb are partially inhibited by Hp.
following subarachnoid hemorrhage [48]. It has been shown
that in preeclampsia, pathologies associated with elevated
level of cell-free Hb, Hp2-1, and Hp2-2 were associated with
increased plasma heme levels and decreased plasma nitrite
concentration [49].
Concomitant with these clinical observations, mechani-
cal studies were performed in order to explain the molecular
basis of these genetically determined differences. It has
been demonstrated that Hp1-1 more efficiently inhibits heme
transfer from MetHb to LDL compared to Hp2-2 [50, 51].
It has been reported that Hp2-2:Hb complex exhibits higher
functional affinity for the macrophage scavenger receptor
CD163 than the Hp1-1:Hb complex [31]. In contrast, Asleh
et al. found that clearance rate of Hp1-1:Hb through CD163
is much higher than that of Hp2-2:Hb [52]. There are, as
well, conflicting data concerning the different antioxidant
properties and different Hb scavenging capacities of Hp1-
1 and Hp2-2. In a recent publication, Lipiski et al. [53]
did not find differences between Hp1-1 and Hp2-2 in Hb
binding and intravascular compartmentalization in vivo.
Furthermore, heme transfer from Hb to endothelial cells
and LDL were equally blocked by Hp1-1 and Hp2-2 [53].
The apparent association of the Hp2-2 genotype with more
severe symptoms in different pathologies might be explained
by differences in size and penetration efficiency of Hp1-1
and Hp2-2. Because Hp2-2 is a large molecule, its diffusion
into deeper compartments might be limited. Clearly, further
investigations are warranted to improve our understanding
of the molecular basis of the epidemiological and clinical
findings related to the Hp polymorphism.
Oxidation of Hb leads to the formation of structurally
altered (e.g., covalently cross-linked) Hb species. It was
hypothesized that these structural changes might be asso-
ciated with the impairment of the endogenous scavenging
pathways. Recent studies have revealed that the elimination
of oxidized Hb species via both high-affinity and low-affinity
pathways can be severely compromised [38, 54].
Heme can be released from Hb upon oxidation. Hem-
opexin (Hx) is an acute-phase plasma protein that binds
heme with the highest affinity of any known protein [55]. Hx
inhibits the catalytic activity of heme in oxidative reactions
[56–58]. Hx-heme complexes are taken up via the scavenger
receptor LDL receptor-related protein 1/CD91 [59]. Although
CD91 is expressed by many different cell types, among them
hepatocytes and macrophages in liver and spleen are the
most important cells in scavenging the circulating Hx-heme
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complexes [60]. Following endocytosis, heme is degraded by
HO-1 and iron is stored by ferritin [61].
Hemoglobin and heme uptake pathways as well as heme
degradation and iron storagemechanismsmust function effi-
ciently to control cell-free Hb- and heme-triggered cellular
and organ damage and to limit renal iron exposure/loss dur-
ing hemolysis or hemorrhage. Hp knock-out and Hx knock-
out mice suffer from oxidative renal injury and elevated
iron loading in the kidney after a strong hemolytic stress
[62, 63]. Surprisingly, Hp/Hx double-null mice show reduced
Hb accumulation in the kidney and improved survival after
a lethal hemolytic stimulus [64]. This suggests that other,
presently uncharacterized, protective mechanisms may be
present in Hp/Hx double-null mice which provide tolerance
in hemolytic stress in a similar way as sickle hemoglobin
confers tolerance to plasmodium infection [65].
5. Biological Effects of Oxidized Hb
5.1. Oxidized Hb as a Prooxidant. Iron compounds can
facilitate the production of hydroxyl radicals from reactive
oxygen species via the Fenton reaction. Sadrzadeh et al.
hypothesized that Hb might provide catalytically active iron
for the Fenton reaction and thus mediate hydroxyl radical
generation [66]. They showed that Hb readily promotes
hydroxyl radical formation in the presence of a superox-
ide anion-generating system [66]. They also examined the
prooxidant effect of Hb on the central nervous system in
vivo. They found that Hb injected into the spinal cord of cats
mediates peroxidation of lipids in the central nervous system.
The iron chelator desferrioxamine prevented the Hb-induced
damage, suggesting that free iron derived from Hb/heme is
the proximate toxic species [67].
Similarly, we later showed thatMetHb but notHb induces
oxidative modification of LDL [42].This effect of MetHb was
inhibited by the heme-scavenging protein Hx and by Hp or
cyanide, agents that either bind free heme or strengthen the
heme-globin bond, highlighting the role of heme release in
this process [42, 68]. Recently, we showed that interactions
between Hb and lipids derived from atheromatous lesions
lead to a feed-forward process of Hb oxidation: conversion of
oxyHb to MetHb, spontaneous heme release, oxidative heme
lysis, iron release, and further lipid peroxidation [23]. We
tested whether highly oxidized forms of Hb such as ferrylHb
might induce lipid peroxidation and found that ferrylHb like
MetHb readily initiates oxidative modification of LDL and
lipids from atheromatous lesions (Potor et al. unpublished
observation) (Figure 1).
Transition metals, particularly iron, markedly potentiate
oxidant damage to cells. Balla and coworkers showed that
MetHb but not Hb synergizes damage from reactive oxygen
species or activated inflammatory cell-mediated damage
on vascular endothelial cells [41] (Figure 1). As might be
expected, this effect of MetHb could be abrogated by the
heme scavenger hemopexin or by strengthening the inter-
action between the heme and globin moieties, once again
emphasizing the critical impact of heme release [41].
5.2. Oxidized Hb as an Inflammatory Mediator. Hemolytic or
hemorrhagic episodes are often associatedwith inflammation
even when infectious agents are absent [69]. Considerable
effort has beenmade to define themediators that trigger such
inflammatory response. Endothelium, the interface between
blood and tissue, has a pivotal role in the inflammatory
response mainly by inducing the leukocyte adhesion cascade
to facilitate the transmigration of inflammatory cells to the
inflamed tissue. It has been shown that endothelial cells
exposed to heme (100 𝜇mol/L) upregulate the expression
of adhesion molecules: intracellular adhesion molecule-1
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1),
and E-selectin [70]. While searching for other mediators of
hemolysis-associated inflammation, we found that ferrylHb
but not native Hb or MetHb triggers the upregulation of the
same proinflammatory adhesion molecules. [29] (Figure 1).
In fact, ferrylHb seems to be a strong agonist of this inflam-
matory response, because it induces adhesion molecules at
concentrations as low as 10 𝜇mol/L, a concentration at which
heme has no effect. Endothelial cells exposed to ferrylHb
show rearrangement of the actin cytoskeleton leading to
disruption of the endothelial cell monolayer, intercellular
gap formation, and increased permeability of the monolayer
[29]. Actin polymerization is required for ferrylHb-induced
inflammatory response and involves the activation of the
c-Jun N-terminal kinase and the p38 mitogen-activated
protein kinase signal transduction pathways [29]. Induction
of inflammation is a unique property of the heavily oxidized
ferrylHb because neither Hb norMetHb triggers these effects
[29] (Figure 1).
Heme itself has been shown to induce inflammation in
mice [71]. In that work, mice were injected intravenously
with heme to obtain 750–1000𝜇mol/L intravascular heme
concentration (≈55–75𝜇mol/kg). Heme enhanced vascular
permeability and increased leukocytesmigration into inflam-
matory areas which was accompanied by the upregulation
of the adhesion molecules in liver and pancreas [71]. Heme
has been shown to be chemotactic for neutrophils when
is injected into the peritoneal cavity of mice at a dose of
only 2–20𝜇mol/kg [72]. We found that ferrylHb injected
intraperitoneally to mice at a dose of 2 𝜇mol/kg induced
a robust inflammatory response leading to the recruitment
of PMN cells in the peritoneum [29]. This effect was not
observedwhenmicewere challengedwithHb orMetHb [29].
Infectious diseases that cause hemolysis are among the
most threatening human diseases. Recently, newmechanisms
have beenproposedwhichmight help explainwhy the combi-
nation of hemolysis and infection is so dangerous. It has been
shown that heme, released fromoxidizedHbupon hemolysis,
amplifies the innate immune response tomicrobialmolecules
such as LPS [73]. This effect of heme is dependent on the
generation of reactive oxygen species [73]. Moreover, heme
activates toll-like receptor 4, a receptor of the innate immune
system that recognizes pathogen-associated molecular pat-
terns such as LPS [74]. In the last couple of years, heme has
been implicated in different disease models (e.g., malaria and
sepsis) as a molecule that can negatively modify the tolerance
of the host to invading pathogens [65, 75–79].
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Overall, oxidized Hb appears to be a two-edged sword,
with both edges unfortunately pointed in the wrong direc-
tion. Not only does free Hb promote oxidative damage
triggered by exogenous and endogenous oxidants, but highly
oxidized forms such as ferryl Hb also cause the upregulation
of proinflammatory adhesion molecules. The net effect of
such upregulation is the recruitment of inflammatory cells
such as neutrophils and macrophages with resultant pro-
motion of local inflammatory reactions. Teleologically, such
responses to oxidized Hb may make sense; the presence
of a hemorrhagic focus implies that the integument has
been breached. Such an incident may permit the entry of
adventitious bacteria, most of which can use Hb iron as
fertilizer and with which they can grow rapidly [80]. In this
light, it may be no surprise that Hp can suppress the Hb-
driven growth of pathogenic bacteria [44].
6. Conclusions
Our growing understanding of the pathophysiologic effects
of extracellular Hb is leading to an improved understanding
of normal and pathologic responses to various forms of Hb
after release from red cells. For most of human history, the
bruise was viewed as simply an interesting lesion, the color
of which evolved over a period of days from red (red cells
and some free oxyHb) to brown (lysed red cells, MetHb)
to green/yellow (biliverdin/bilirubin). Now, it seems there
may be more going on than meets the eye, especially the
formation of different forms of oxidized Hb with varying
biological activities. The complex system which has evolved
to control and dispose of cell-free Hb generally works well
unless overwhelmedby excessive hemorrhage or hemolysis. It
is now becoming clear that cell-free, variously oxidized Hb is
capable of promoting oxidation and inflammatory responses.
This occurs through (1) the release of free heme (a toxic
prooxidant molecule), (2) increasing expression of vascular
adhesion molecules, and (3) the subsequent promotion of
inflammatory processes. Fuller understanding of this chain of
events may lead to the development of improved diagnostics
and therapeutics meant to interrupt the pathologic effects of
cell-free Hb.
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